Erasca
$16.19
68
-$0.07-0.43% Friday 20:00
+$0.00+0%Friday 23:30After hours
Statistics
Day High
16.21
Day Low
16.16
52W High
24.28
52W Low
1.47
Volume
63,790
Avg. Volume
-
Mkt Cap
5.66B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.6
-0.43
-0.27
-0.1
Expected EPS
-0.127396
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-124.55MNet Income
Analyst Ratings
22.88Average Price Target
The highest estimate is 30.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy 75%
Hold 25%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ERAS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap233.78B
Gilead Sciences
GILD
Mkt Cap180.64B
Merck
MRK
Mkt Cap366B
Bristol-Myers Squibb
BMY
Mkt Cap136B
Novartis
NVS
Mkt Cap292.35B
Pfizer
PFE
Mkt Cap159.36B
Roche
RHHBY
Mkt Cap334.28B
Array Technologies
ARRY
Mkt Cap706.9M
About
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.
Show more...
CEO
Jonathan E. Lim
Employees
103
Country
United States
ISIN
US29479A1088
Listings
0 Comments
Share your thoughts
FAQ
What is Erasca stock price today?▼
The current price of ERAS is $16.19 USD — it has decreased by -0.43% in the past 24 hours. Watch Erasca stock price performance more closely on the chart.
What is Erasca stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Erasca stocks are traded under the ticker ERAS.
Is Erasca stock price growing?▼
ERAS stock has fallen by -10.21% compared to the previous week, the month change is a -11.38% fall, over the last year Erasca has showed a +905.59% increase.
What is Erasca market cap?▼
Today Erasca has the market capitalization of 5.66B
When is the next Erasca earnings date?▼
Erasca is going to release the next earnings report on November 11, 2026.
What were Erasca earnings last quarter?▼
ERAS earnings for the last quarter are -0.14 USD per share, whereas the estimation was -0.11 USD resulting in a -25.71% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Erasca revenue for the last year?▼
Erasca revenue for the last year amounts to 0 USD.
What is Erasca net income for the last year?▼
ERAS net income for the last year is -124.55M USD.
How many employees does Erasca have?▼
As of September 06, 2026, the company has 103 employees.
In which sector is Erasca located?▼
Erasca operates in the Health & Wellness sector.
When did Erasca complete a stock split?▼
Erasca has not had any recent stock splits.
Where is Erasca headquartered?▼
Erasca is headquartered in SAN DIEGO, United States.